• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分枝杆菌药敏检测技术的进展以及药敏检测在结核病控制项目中的应用。

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

作者信息

Canetti G, Fox W, Khomenko A, Mahler H T, Menon N K, Mitchison D A, Rist N, Smelev N A

出版信息

Bull World Health Organ. 1969;41(1):21-43.

PMID:5309084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2427409/
Abstract

In a paper arising out of an informal international consultation of specialists in the bacteriology of tuberculosis held in 1961, an attempt was made to formulate criteria, and specify technical procedures, for reliable tests of sensitivity (the absolute-concentration method, the resistance-ratio method and the proportion method) to the 3 main antituberculosis drugs (isoniazid, streptomycin and p-aminosalicylic acid). Seven years later, a further consultation was held to review the latest developments in the field and to suggest how sensitivity tests might be put to practical use in tuberculosis control programmes. The participants reached agreement on how to define drug sensitivity and resistance, and stressed the importance of using a discrimination approach to the calibration of sensitivity tests. Their views are contained in the present paper, which also includes descriptions of the sensitivity tests used by the Medical Research Council of Great Britain for first- and second-line drugs (minimal inhibitory concentration and resistance-ratio methods), the two main variants of the proportion method developed by the Institut Pasteur, Paris, and a method for calibrating sensitivity tests.

摘要

在一篇源自1961年结核病细菌学专家非正式国际咨询会议的论文中,人们尝试制定标准并明确技术程序,用于对3种主要抗结核药物(异烟肼、链霉素和对氨基水杨酸)进行可靠的敏感性测试(绝对浓度法、耐药比法和比例法)。7年后,又举行了一次咨询会议,以回顾该领域的最新进展,并就如何在结核病控制项目中实际应用敏感性测试提出建议。与会者就如何定义药物敏感性和耐药性达成了一致,并强调了采用鉴别方法校准敏感性测试的重要性。他们的观点包含在本文中,本文还介绍了英国医学研究理事会用于一线和二线药物的敏感性测试方法(最低抑菌浓度法和耐药比法)、巴黎巴斯德研究所开发的比例法的两种主要变体,以及一种校准敏感性测试的方法。

相似文献

1
Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.分枝杆菌药敏检测技术的进展以及药敏检测在结核病控制项目中的应用。
Bull World Health Organ. 1969;41(1):21-43.
2
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.分枝杆菌:药物敏感性和耐药性检测的实验室方法
Bull World Health Organ. 1963;29(5):565-78.
3
Comparison of the resistance ratio and proportion methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis.结核分枝杆菌抗菌药物敏感性试验中电阻比法与比例法的比较。
J Med Assoc Thai. 2001 Oct;84(10):1467-76.
4
Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method.采用高通量、可重复的绝对浓度法对结核分枝杆菌复合群进行药物敏感性检测。
J Clin Microbiol. 2007 Aug;45(8):2662-8. doi: 10.1128/JCM.00244-07. Epub 2007 May 30.
5
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.世界卫生组织/国际防痨和肺部疾病联盟超国家实验室网络中结核分枝杆菌药敏试验的质量保证计划:第一轮能力验证试验
Int J Tuberc Lung Dis. 1997 Jun;1(3):231-8.
6
[Use of the proportion method in the determination of the sensitivity of Mycobacterium tuberculosis to antibacterial agents].
Lab Delo. 1971;4:225-8.
7
[Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].[使用小川培养基,采用Bactec MGIT 960 AST法和传统比例法对结核分枝杆菌进行异烟肼药敏试验的比较研究]
Kekkaku. 2007 May;82(5):449-54.
8
[Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].[从患者分离出的非典型分枝杆菌对一线和二线抗结核药物的药敏性]
Antibiotiki. 1971 Feb;16(2):149-52.
9
[Antitubercular effect of capreomycin in vitro].卷曲霉素的体外抗结核作用
Gruzlica. 1969 Jul;37(7):629-35.
10
[Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].[2002年日本抗结核药物耐药性调查:结果的外部质量评估]
Kekkaku. 2007 Mar;82(3):155-64.

引用本文的文献

1
Xpert MTB/XDR Assay for Detection of Resistance to Isoniazid, Fluoroquinolone, Aminoglycoside, and Ethionamide Among Patients with Pulmonary Tuberculosis in Bangladesh.用于检测孟加拉国肺结核患者中对异烟肼、氟喹诺酮、氨基糖苷类和乙硫异烟胺耐药性的Xpert MTB/XDR检测法
Infect Dis Ther. 2025 Apr;14(4):803-818. doi: 10.1007/s40121-025-01127-0. Epub 2025 Mar 24.
2
Comparative Proteomic Analysis of Cell Wall Proteins of Aminoglycosides Resistant and Sensitive Clinical Isolates.氨基糖苷类耐药和敏感临床分离株细胞壁蛋白的比较蛋白质组学分析
Curr Protein Pept Sci. 2025;26(5):392-405. doi: 10.2174/0113892037334796240927055243.
3
Comparisons of genome assembly tools for characterization of genomes using hybrid sequencing technologies.利用混合测序技术对基因组进行特征分析的基因组组装工具比较。
PeerJ. 2024 Aug 29;12:e17964. doi: 10.7717/peerj.17964. eCollection 2024.
4
Targeted next-generation sequencing of from patient samples: lessons learned from high drug-resistant burden clinical settings in Bangladesh.对来自孟加拉国高耐药负担临床环境的患者样本进行靶向下一代测序:经验教训。
Emerg Microbes Infect. 2024 Dec;13(1):2392656. doi: 10.1080/22221751.2024.2392656. Epub 2024 Aug 26.
5
Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trial.含左氧氟沙星 4 个月方案与 6 个月方案治疗浅表淋巴结结核患者的疗效和耐受性比较:一项随机试验。
BMC Infect Dis. 2024 Jul 25;24(1):729. doi: 10.1186/s12879-024-09511-w.
6
Multidrug-resistant Mycobacterium tuberculosis transmission in Shandong, China.中国山东耐多药结核分枝杆菌传播。
Medicine (Baltimore). 2024 Mar 22;103(12):e37617. doi: 10.1097/MD.0000000000037617.
7
Targeted genome sequencing for tuberculosis drug susceptibility testing in South Africa: a proposed diagnostic pipeline.南非用于结核病药敏试验的靶向基因组测序:一种拟议的诊断流程。
Access Microbiol. 2024 Feb 16;6(2). doi: 10.1099/acmi.0.000740.v3. eCollection 2024.
8
Molecular Detection of Multidrug Resistance and Characterizations of Mutations in Using Polycarbonate Track-Etched Membrane Based DNA Bio-Chip.使用聚碳酸酯径迹蚀刻膜基DNA生物芯片对多药耐药性进行分子检测及突变特征分析。
Indian J Microbiol. 2024 Mar;64(1):92-99. doi: 10.1007/s12088-023-01116-2. Epub 2023 Nov 24.
9
Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracy.表型与基因型不一致的利福平药敏试验在结核病中的诊断价值:对诊断准确性的影响。
Microbiol Spectr. 2024 Jan 11;12(1):e0163123. doi: 10.1128/spectrum.01631-23. Epub 2023 Nov 20.
10
Genomic markers of drug resistance in populations with minority variants.具有少数变异的人群中的药物耐药性的基因组标记物。
J Clin Microbiol. 2023 Oct 24;61(10):e0048523. doi: 10.1128/jcm.00485-23. Epub 2023 Sep 26.

本文引用的文献

1
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.分枝杆菌:药物敏感性和耐药性检测的实验室方法
Bull World Health Organ. 1963;29(5):565-78.
2
[Contribution to the elimination of discrepancies in the determination of tubercle bacilli resistant to streptomycin].
Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1962;126:84-97.
3
[Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation].[采用比例法测定结核杆菌对抗菌药物的敏感性。方法、耐药标准、结果与解读]
Rev Tuberc Pneumol (Paris). 1963 Feb-Mar;27:217-72.
4
Identification of tubercle bacilli from Indian patients with pulmonary tuberculosis.从印度肺结核患者中鉴定结核杆菌。
Bull World Health Organ. 1961;25(6):747-58.
5
Present aspects of bacterial resistance in tuberculosis.结核病中细菌耐药性的当前状况。
Am Rev Respir Dis. 1965 Nov;92(5):687-703. doi: 10.1164/arrd.1965.92.5.687.
6
Towards an international standardization of resistance tests on mycobacteria.
Scand J Respir Dis. 1968;49(2):141-52.
7
[Current data on primary resistance in pulmonary tuberculosis in adults in France. 2d survey of the Centre d'Etudes sur la Resistance Primaire: 1965-1966].
Rev Tuberc Pneumol (Paris). 1967 Jun;31(4):433-74.